172 related articles for article (PubMed ID: 33822245)
1. Pseudomonas aeruginosa infection in respiratory samples in children with neurodisability-to treat or not to treat?
Gregson E; Thomas L; Elphick HE
Eur J Pediatr; 2021 Sep; 180(9):2897-2905. PubMed ID: 33822245
[TBL] [Abstract][Full Text] [Related]
2. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-resistant
Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
[TBL] [Abstract][Full Text] [Related]
4. Development of Chronic Pseudomonas aeruginosa-Positive Respiratory Cultures in Children with Tracheostomy.
Russell CJ; Simon TD; Neely MN
Lung; 2019 Dec; 197(6):811-817. PubMed ID: 31673781
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa bloodstream infection at a tertiary referral hospital for children.
Dame JA; Beylis N; Nuttall J; Eley B
BMC Infect Dis; 2020 Oct; 20(1):729. PubMed ID: 33028225
[TBL] [Abstract][Full Text] [Related]
7. Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection.
Viasus D; Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Chumbita M; Moreno-García E; Fernández-Avilés F; Gutiérrez-Garcia G; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
Clin Microbiol Infect; 2020 Mar; 26(3):345-350. PubMed ID: 31295551
[TBL] [Abstract][Full Text] [Related]
8. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of antibiotic susceptibility patterns and clinical features of mucoid and non-mucoid
Luo M; Li S; Luo W
Front Public Health; 2024; 12():1333477. PubMed ID: 38389944
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
11. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
12. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.
Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A
J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
Cho CH; Lee SB
BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
[TBL] [Abstract][Full Text] [Related]
14. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Greally P; Whitaker P; Peckham D
Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis.
Blanchard AC; Horton E; Stanojevic S; Taylor L; Waters V; Ratjen F
J Cyst Fibros; 2017 May; 16(3):395-400. PubMed ID: 28189634
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
[TBL] [Abstract][Full Text] [Related]
17. Description of Respiratory Microbiology of Children With Long-Term Tracheostomies.
McCaleb R; Warren RH; Willis D; Maples HD; Bai S; O'Brien CE
Respir Care; 2016 Apr; 61(4):447-52. PubMed ID: 26670471
[TBL] [Abstract][Full Text] [Related]
18. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of 22 cases community-acquired Pseudomonas aeruginosa urinary tract infection].
Fu XH; Zhou W; Zhang XM; Yin YB; Jing CM; Liu L; Zhao J
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):298-301. PubMed ID: 23927805
[TBL] [Abstract][Full Text] [Related]
20. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
